Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
26
TCNNF Quote, Financials, Valuation and Earnings
Last price:
$4.12
Seasonality move
:
9.74%
Day range:
$4.00 - $4.25
52-week range:
$3.02 - $13.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.66x
P/B ratio:
0.63x
Volume:
277.7K
Avg. volume:
360.2K
1-year change:
-59.95%
Market cap:
$781.5M
Revenue:
$1.2B
EPS (TTM):
-$0.82
Earnings Data
Next earnings date for TCNNF
Aug 06
2025
Most recent earnings per share
-$0.17
Missed by $0.08
(May 9/2025)
Consensus Estimate
-$0.09
(May 9/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TCNNF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $296.8M | -- | -- | -$0.07 | -- |
| 08/06/2025 | Q2 | $303M | -- | -- | -$0.06 | -- |
| 05/09/2025 | Q1 | $294.1M | $297.8M | -$0.17 | -$0.09 | -$0.08 |
| 02/28/2025 | Q4 | $292.4M | $301.1M | -$0.27 | -$0.35 | $0.08 |
| 11/05/2024 | Q3 | $289.6M | $284.3M | -$0.33 | -$0.13 | -$0.20 |
| 08/09/2024 | Q2 | $293.3M | $303.4M | -$0.05 | -$0.09 | $0.04 |
| 05/09/2024 | Q1 | $285.7M | $297.6M | -$0.17 | -$0.11 | -$0.06 |
| 02/29/2024 | Q4 | $268M | $287M | -$0.18 | -$0.13 | -$0.05 |
| 11/09/2023 | Q3 | -- | -- | -$0.14 | -$0.15 | $0.01 |
| 06/30/2023 | Q2 | -- | -- | -$1.80 | -$0.18 | -$1.62 |
| 03/31/2023 | Q1 | -- | -- | -$0.34 | -$0.16 | -$0.18 |
| 12/31/2022 | Q4 | -- | -- | -$0.43 | -$0.08 | -$0.35 |
| 09/30/2022 | Q3 | -- | -- | -$0.61 | -$0.03 | -$0.58 |
| 06/30/2022 | Q2 | -- | -- | -$0.12 | $0.08 | -$0.20 |
| 03/31/2022 | Q1 | -- | -- | -$0.17 | $0.06 | -$0.23 |
| 12/31/2021 | Q4 | -- | -- | -$0.60 | $0.16 | -$0.76 |
| 09/30/2021 | Q3 | -- | -- | $0.14 | $0.28 | -$0.14 |
| 06/30/2021 | Q2 | -- | -- | $0.31 | $0.30 | $0.01 |
| 03/31/2021 | Q1 | -- | -- | $0.24 | $0.31 | -$0.07 |
| 12/31/2020 | Q4 | -- | -- | $0.01 | $0.24 | -$0.23 |
| 09/30/2020 | Q3 | -- | -- | $0.04 | $0.21 | -$0.17 |
| 06/30/2020 | Q2 | -- | -- | $0.06 | $0.12 | -$0.06 |
| 03/31/2020 | Q1 | -- | -- | $0.12 | $0.11 | $0.01 |
| 12/31/2019 | Q4 | -- | -- | $0.34 | $0.11 | $0.23 |
| 09/30/2019 | Q3 | -- | -- | $0.55 | $0.13 | $0.42 |
| 06/30/2019 | Q2 | -- | -- | $0.52 | $0.12 | $0.40 |
| 03/31/2019 | Q1 | -- | -- | $0.13 | $0.11 | $0.02 |
| 12/31/2018 | Q4 | -- | -- | $0.10 | $0.07 | $0.03 |
Trulieve Cannabis Earnings Questions
-
How Much did Trulieve Cannabis Generate in Revenue Last Quarter?
Trulieve Cannabis reported $297.8M worth of top line sales in its most recent quarter.
-
Did Trulieve Cannabis Beat Earnings Last Quarter?
Trulieve Cannabis announced earnings per share of -$0.17 which represents a miss of analyst forecast a -$0.09 per share.
-
Is Trulieve Cannabis Profitable?
Trulieve Cannabis reported $183.2M that represents $0.96 per share over the last quarter.
-
What is the Analyst Consensus for Trulieve Cannabis EPS Next Year?
Trulieve Cannabis's earnings are forecast to decrease from -$0.82 per share to -$0.75 per share next year representing a decrease of -72.15%.
-
When is Trulieve Cannabis's Earnings Date?
Trulieve Cannabis's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
